These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 3080868)
1. Influence of artificial fat emulsions on the composition of serum lipoproteins in humans. Hailer S; Wolfram G Am J Clin Nutr; 1986 Feb; 43(2):225-33. PubMed ID: 3080868 [TBL] [Abstract][Full Text] [Related]
2. Changes in serum lipoproteins in humans following the infusion of a fat emulsion containing medium- and long-chain triglycerides. Hailer S; Wolfram G; Zöllner N Eur J Clin Invest; 1987 Oct; 17(5):402-7. PubMed ID: 3121343 [TBL] [Abstract][Full Text] [Related]
3. Changes of HDL subfraction concentration and particle size by intralipid in vivo. Sakuma N; Lin C; Matsumoto Y; Ikeuchi R; Ichikawa T; Hirata H; Noguchi Y; Fujinami T Atherosclerosis; 1988 Nov; 74(1-2):91-8. PubMed ID: 3145750 [TBL] [Abstract][Full Text] [Related]
4. Anomalies in composition of uremic lipoproteins isolated by gradient ultracentrifugation: relative enrichment of HDL in apolipoprotein C-III at the expense of apolipoprotein A-I. Atger V; Duval F; Frommherz K; Drüeke T; Lacour B Atherosclerosis; 1988 Nov; 74(1-2):75-83. PubMed ID: 3145749 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity. Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786 [TBL] [Abstract][Full Text] [Related]
6. Relationship of serum triglyceride concentration to lipoprotein composition and concentration in normolipidemic and hyperlipidemic subjects. Sommariva D; Branchi A; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Ottomano C; Fasoli A Ric Clin Lab; 1988; 18(4):281-90. PubMed ID: 3150123 [TBL] [Abstract][Full Text] [Related]
7. The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction. Murai A; Miyahara T; Tanaka T; Sako Y; Nishimura N; Kameyama M Artery; 1985; 12(4):234-43. PubMed ID: 3935096 [TBL] [Abstract][Full Text] [Related]
9. Changes of high density lipoprotein subfraction concentration and composition by intralipid in vivo and by lipolysis of intralipid in vitro. Taskinen MR; Nikkilä EA; Kuusi T; Tulikoura I Arteriosclerosis; 1983; 3(6):607-15. PubMed ID: 6651616 [TBL] [Abstract][Full Text] [Related]
10. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency. Angquist KA; Johnson O; Ericsson M; Tollin C Acta Chir Scand; 1982; 148(8):675-8. PubMed ID: 6820598 [TBL] [Abstract][Full Text] [Related]
11. Effects of castration and testosterone administration on serum lipoproteins and their apoproteins in male spontaneously hypertensive rat. Takeuchi N; Go S; Murase M; Nomura Y; Takase H; Uchida K Endocrinology; 1986 May; 118(5):1787-94. PubMed ID: 3084207 [TBL] [Abstract][Full Text] [Related]
12. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids. Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of gemfibrozil on lipoprotein metabolism. Saku K; Gartside PS; Hynd BA; Kashyap ML J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles. Iriyama K; Nishiwaki H; Terashima H; Tonouchi H; Miki C; Suzuki H; Carpentier YA JPEN J Parenter Enteral Nutr; 1988; 12(1):60-2. PubMed ID: 3125357 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375 [TBL] [Abstract][Full Text] [Related]
16. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Hamsten A; Walldius G; Dahlén G; Johansson B; De Faire U Atherosclerosis; 1986 Feb; 59(2):223-35. PubMed ID: 3083833 [TBL] [Abstract][Full Text] [Related]
17. [Value of the analysis of lipoproteins after myocardial infarction]. Dewailly P; Mellin D; Moulin S; Rouget JP; Sezille G; Jaillard J Presse Med; 1983 Jul 9-16; 12(29):1807-10. PubMed ID: 6224195 [TBL] [Abstract][Full Text] [Related]
18. Capacity of lipoproteins to act as substrates for lecithin:cholesterol acyltransferase. Enhancement by pre-incubation with an artificial triacylglycerol emulsion. Hopkins GJ; Barter PJ Biochim Biophys Acta; 1984 Jun; 794(1):31-40. PubMed ID: 6733128 [TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. Wang CS; Alaupovic P; Gregg RE; Brewer HB Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493 [TBL] [Abstract][Full Text] [Related]
20. Density distribution, characterization, and comparative aspects of the major serum lipoproteins in the common marmoset (Callithrix jacchus), a New World primate with potential use in lipoprotein research. Chapman MJ; Mc Taggart F; Goldstein S Biochemistry; 1979 Nov; 18(23):5096-108. PubMed ID: 227447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]